We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Newly Identified Oncogene Links Amino Acids to Colorectal Cancer Development

By LabMedica International staff writers
Posted on 02 Nov 2014
Print article
Cancer researchers have identified a novel oncogene—and possible drug target—that promotes development of colorectal cancer by interacting with amino acids to activate the pro-cancer mTORC1 signaling complex.

mTOR (mammalian target of rapamycin) is a master regulator of protein synthesis that under ordinary conditions induces cells to grow and divide. In situations of severe nutrient deprivation mTOR closes down protein synthesis so that the cell can conserve energy. However, in cancer cells the mTOR pathway misfires and signals tumor cells to grow, divide, undergo metastasis, and invade new, healthy tissues.

Investigators at Rutgers University (New Brunswick, NJ, USA) have been looking at the interaction between amino acids and the small GTPase enzyme Rab1A, which is a key switch for amino acid signaling.

They reported in the October 13, 2014, online edition of the journal Cancer Cell that amino acids activated Rab1A, which then stimulated Rheb (another small GTPase) to interact with the mTORC1 complex in the cells' Golgi apparatus. They found that Rab1A overexpression promoted mTORC1 signaling and oncogenic growth in an amino acid- and mTORC1-dependent manner. Blocking Rab1A activity selectively inhibited oncogenic growth of Rab1-overexpressing cancer cells. Furthermore, Rab1A was found to be overexpressed in colorectal cancer, which was correlated with elevated mTORC1 signaling, tumor invasion, progression, and poor prognosis. In contrast, overexpression of Rab1A increased sensitivity of cancer cells toward the drug rapamycin, which blocks the growth-stimulating effect of mTORC1.

Senior author Dr. X. F. Steven Zheng, professor of pharmacology at Rutgers University, said, “In further elucidating the role Rab1A plays in amplifying amino acid signaling, we can further understand this impact on the mTORC1 protein. Especially since elevated levels of mTORC1 signaling is found in colorectal cancer, new therapy options targeted toward mTORC1 can be explored.”

Related Links:

Rutgers University



Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
Lab Sample Rotator
H5600 Revolver

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.